Polen Capital China Growth ETF (PCCE)

The Polen Capital China Growth ETF (PCCE) is an actively managed fund created by asset manager Polen Capital to invest in what it believes are the highest-quality, fastest-growing companies listed in China and Hong Kong — firms typically mid-cap or larger, with strong revenue growth, competitive advantages, and management teams that can compound shareholder value over time.

Origins and the Polen Capital approach

Polen Capital is a Tampa, Florida-based asset manager founded in 1989. The firm’s investment philosophy emphasises buying quality businesses growing faster than the broad market and holding them for the long term. The firm made a deliberate choice to create a China-focused vehicle around that same philosophy: rather than indexing to the broad Chinese market (which includes many state-owned, slow-growing, or low-margin businesses), PCCE applies Polen’s quality-and-growth screen to Chinese equities specifically. The fund launched in the 2010s as China’s stock markets became more accessible to foreign capital.

What the fund holds

PCCE’s typical portfolio includes 30–50 companies listed on the Shanghai Stock Exchange, the Shenzhen Stock Exchange, or the Hong Kong Stock Exchange. The fund skews toward larger, more liquid names because those companies are easier for a US-domiciled fund to buy and sell. Typical holdings include leading consumer-goods companies, pharmaceutical and biotech firms, real-estate developers, internet and technology companies, and industrial manufacturers — all of which are Chinese or Hong Kong-domiciled and believed by Polen’s team to be high-quality and in fast-growing markets.

The fund does not own Chinese state-owned enterprises wholesale; it is selective, choosing only those SOEs the team believes are well-run and have real competitive advantage. Much of the portfolio is concentrated in the “new economy” side of China — e-commerce, consumer discretionary, technology — rather than old-line heavy industry or commodity sectors.

The evolution of China as an investment destination

When Polen created PCCE in the early-to-mid 2010s, Chinese equities were beginning to open to foreign investors, but capital controls and regulatory barriers limited access. Hong Kong remained the easiest point of entry. Since then, stock-connect programs have eased cross-border trading, and Chinese regulators have been more permissive (though still highly interventionist) about foreign ownership of mainland-listed shares. PCCE’s mandate has evolved alongside this thaw: it now can invest a larger slice in mainland stocks, not just Hong Kong names.

The fund has also lived through China’s regulatory surprises. The government’s 2021 crack-down on technology companies, the education sector, and real-estate developers wiped out significant value in portfolios that held those stocks heavily. PCCE’s active management meant it was not mechanically exposed to the heaviest losses, but the volatility and unpredictability of Chinese policy changes nevertheless hit the fund.

Why active management in China matters

A passive, indexed approach to Chinese equities — holding every company in proportion to its market cap — would give investors exposure to state-owned banks, commodity producers, and heavily regulated industries where competition is limited and margins are thin. Polen’s thesis is that active selection can avoid the worst compounders and find companies with real competitive advantages, better management, and more sustainable growth. Whether that translates to better returns than a passive China index depends on the team’s skill and on how much the fund’s expense ratio (higher than a passive alternative) is offset by better stock-picking.

The risks and volatility

China risk is the most obvious hazard. Political changes, unexpected regulatory shifts, and capital controls can materially hurt returns. The government’s willingness to intervene in private companies for social goals (tech regulation, education-sector oversight) is not typical in developed markets and makes China a more uncertain investment destination. Foreign investors in Chinese equities also face the possibility, however remote, that large-scale capital controls could restrict their ability to move money out of China.

Currency risk is a second factor. Many of PCCE’s holdings are denominated in Chinese yuan or Hong Kong dollars. If the yuan depreciates against the US dollar, the fund’s returns to US investors will be depressed even if the underlying companies perform well.

Valuation can also be a concern. Chinese growth stocks often trade at premium valuations compared to US growth stocks, reflecting their faster growth rates. If growth expectations are revised downward, valuations can compress sharply. PCCE invests in quality businesses, which should be more resilient, but quality is not a guarantee against multiple compression.

How to research PCCE

Review Polen Capital’s most recent commentary on the China market and the fund’s positioning to understand management’s current conviction and concerns. Check the fact sheet for the fund’s top 10 holdings, sector breakdown, and recent returns. Comparing PCCE’s performance over 3-, 5-, and 10-year periods against a broad China index (like the MSCI China Index, which PCCE does not track but serves as a useful benchmark) shows whether the active selection has added value after fees.

Also examine turnover — how often Polen trades the holdings. High turnover suggests active management, but it also raises costs. Moderate turnover combined with consistent, positive excess returns would signal the team is adding value. PCCE’s higher expense ratio (typically 0.70–1.00 per cent, significantly more than a passive China fund) is the cost of that active management and must be justified by the fund’s results and your confidence in Polen Capital’s China expertise.